GMANews.TV - RP challenges patent on drug vs high blood
A petition was filed Tuesday to cancel Pfizer's Philippine patent on the anti-hypertension drug Norvasc after a U.S. court invalidated the company's rights over its second best-selling medicine.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment